Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-04-09

Clinical Trial Update: Clinical Evaluation of T.R.U.E. TEST® Fragrance Mix and Thimerosal Allergens:Bioequivalence of PVP Formulations [Phase 2]

View source ↗

Summary

Phase 2 study evaluating bioequivalence of polyvinylpyrrolidone (PVP) formulations used in the T.R.U.E. TEST fragrance mix and thimerosal allergens for patch te…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PVP formulations (Polyvinylpyrrolidone formulations)
  • T.R.U.E. TEST Fragrance Mix (Fragrance mix allergen)
  • Thimerosal (Thimerosal)

Snippet

Sponsor: Allerderm | Conditions: Dermatitis, Contact | Phase 2 | Status: COMPLETED | Results posted: 2018-04-09